Rucaparib in recurrent ovarian cancer: real-world experience from the rucaparib early access programme in Spain - A GEICO study. - Yubero, Alfonso; Barquín, Aranzazu; Estévez, Purificación; Pajares, Bella; Sánchez, Luisa; Reche, Piedad; Alarcón, Jesús; Calzas, Julia; Gaba, Lydia; Fuentes, José; Santaballa, Ana; Salvador, Carmen; et al. (BMC Cancer, 2022)